跳至主要内容
临床试验/IRCT20161207031288N6
IRCT20161207031288N6招募中2 期

consideration of clinical safety and efficacy of topical formulation of polyphenolic extract of punica granatum on patients with mild to moderate forms of melasma

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Mild to moderate melasma with minimum grade of Melasma area and severity index = 1
  • Age range 18-50
  • Signing consent form, voluntarily and knowingly

排除标准

  • Pregnancy or lactation
  • Using oral corticosteroids or isotretinoin within 28 days prior to the study
  • Any active skin disease at test area including rosacea, eczema, atrophy, acne
  • Using any light sensitizing medicine within 3 months prior to the study
  • Use of topical lightening products like alpha hydroxy acid, beta hydroxy acid, and retinoid component within 21 days prior to the study
  • Documented allergy to components of the cream
  • History of laser treatment or dermabrasion or deep facial peeling within the past 3 months prior to the study
  • Using contraceptive or hormonal medicines

研究者

相似试验